Objective response to immune checkpoint inhibitor therapy in NRAS-mutant melanoma: A systematic review and meta-analysis.
Front Med (Lausanne)
; 10: 1090737, 2023.
Article
in En
| MEDLINE
| ID: mdl-36873887
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Systematic_reviews
Language:
En
Journal:
Front Med (Lausanne)
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: